# Prophylactic Use of Milrinone After Congenital Heart Surgery in Infants

> **NCT03823781** · PHASE3 · UNKNOWN · sponsor: **Shanghai Children's Medical Center** · enrollment: 520 (estimated)

## Conditions studied

- Low Cardiac Output Syndrome
- Cardiac Surgical Procedures
- Infant

## Interventions

- **DRUG:** Milrinone
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03823781
- **Lead sponsor:** Shanghai Children's Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02
- **Primary completion:** 2021-01
- **Final completion:** 2021-07
- **Target enrollment:** 520 (ESTIMATED)
- **Last updated:** 2019-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03823781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03823781, "Prophylactic Use of Milrinone After Congenital Heart Surgery in Infants". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03823781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*